We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Neighbor Cell Signals Cause Function Change in Response

By LabMedica International staff writers
Posted on 14 Jan 2019
A molecular mechanism has been identified that maintains cell identity via an active process, which is mediated by repressive signals released by neighboring cells that curb an intrinsic trend of differentiated cells to change.

Investigators at the University of Bergen (Norway) and their collaborators were working with a mouse diabetes model as part of their study of the forces that restrict regeneration and maintain cell identity following injury. More...
In the diabetes model, following beta-cell loss, 1–2% of the glucagon-producing alpha-cells spontaneously began producing insulin. Normally, in the pancreas alpha-cells produce glucagon, and this increases blood sugar levels. Beta-cells produce insulin, which decreases glucagon levels while delta-cells produce somatostatin, which controls the regulation of the alpha and beta cells.

The investigators reported in the October 22, 2018, issue of the journal Nature Cell Biology that adaptive alpha-cell identity changes were blocked by intra-islet insulin- and Smoothened-mediated signaling, among others. Smoothened is a Class Frizzled (Class F) G protein-coupled receptor that is a component of the hedgehog signaling pathway.

The combination of beta-cell loss or insulin-signaling inhibition together with Smoothened inactivation in alpha- or delta-cells stimulated insulin production in a greater number of alpha-cells. Thus, the maintenance of cell identity was seen to be an active process mediated by repressive signals, which were released by neighboring cells and curbed an intrinsic trend of differentiated cells to change.

"We are possibly facing the start of a totally new form of treatment for diabetes, where the body can produce its own insulin, with some start-up help," said contributing author Dr. Luiza Ghila, a researcher in the department of clinical science at the University of Bergen. "If we gain more knowledge about the mechanisms behind this cell flexibility, then we could possibly be able to control the process and change more cells' identities so that more insulin can be produced. Furthermore, the cells' ability to change identity and function may be a decisive discovery in treating other diseases caused by cell death, such as Alzheimer´s disease and cellular damage due to heart attacks."

Related Links:
University of Bergen


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.